Article: Human Genome Sciences Establishes New Subsidiary in Europe.

- Will Manage Clinical Trials and Clinical Research Collaborations in European Countries -

Human Genome Sciences, Inc. announced today the creation of Human Genome Sciences Europe GmbH, a new subsidiary that will be responsible for European clinical trials of the company's rapidly evolving portfolio of new drugs in clinical and late-stage preclinical development. The new subsidiary will be based in Dusseldorf, Germany, and will report to David C. Stump, M.D., Senior Vice President, Drug Development.

(Photo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

Florian Bieber, M.D., formerly Head of the Cardiovascular, Metabolic Disorders, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!